IAS
HRMY icon

IMA Advisory Services’s Harmony Biosciences HRMY Stock Holding History

IMA Advisory Services’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$980 Sell
35
-5
-13% -$164 ﹤0.01% 779
2025
Q4 		$1.5K Buy
+40
New +$1.31K ﹤0.01% 726

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

IMA Advisory Services's HRMY Position: Q1 2026 in Review

IMA Advisory Services reduced its Harmony Biosciences (HRMY) stake by 13% in Q1 2026, selling an estimated $164 and leaving 35 shares worth $980. The position accounts for ﹤0.01% of the portfolio, ranked #779.

IMA Advisory Services first reported a position in HRMY in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.5K in Q4 2025. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • IMA Advisory Services held 35 shares of Harmony Biosciences worth $980 as of Q1 2026.
  • IMA Advisory Services sold 5 Harmony Biosciences shares in Q1 2026, an estimated $164.
  • Harmony Biosciences made up ﹤0.01% of IMA Advisory Services's portfolio in Q1 2026, its #779 holding.
  • IMA Advisory Services first reported a position in Harmony Biosciences in Q4 2025 and has held it in 2 quarters since.
  • IMA Advisory Services's Harmony Biosciences position peaked at $1.5K in Q4 2025.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on IMA Advisory Services's 13F filing for Q1 2026, filed 6 May 2026.